오피오이드약 시장 : 약제 유형별, 용도별, 투여 경로별, 유통 채널별, 지역별

The global opioid drugs market is estimated to be valued at US$ 45.0 billion in 2023 and is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030).

Global Opioid Drugs Market Share (%), By Drug Class, 2023

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically, they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. One of the first opioid drugs, 'morphine', was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous systems, thus providing relief from pain. Opioids are administered in the form of oral pills, parenteral liquids, patches, or lozenges. There are different types of prescription opioids available, such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone, which are prescribed by physicians for mainly treating pain.

Market Dynamics

The key market players are focused on organic growth strategies such as product launches and approval, and this is expected to drive market growth for the forecast period. Moreover, the growing geriatric population globally is expected to increase the usage of opioids, as elderly people are at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Thus, the rising prevalence of old people is expected to drive market growth. In addition, the increasing prevalence of chronic diseases such as cancer, chronic pain due to arthritis, lower back pain, fibromyalgia, and postsurgical pain is also expected to increase the usage of opioids as pain relieving agents, which is expected to drive market growth for the forecast period. For instance, as per the factsheet published by the Center for Disease Control and Prevention (CDC) in October 2021, about 1 in 4 U.S. adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis, and this is expected to reach 78 million by 2045.

Key features of the study:

• This report provides an in-depth analysis of the global opioid drugs market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global opioid drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global opioid drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid drugs market.

Opioid Drugs Market Detailed Segmentation:

• By Drug Class:
  • Alkaloids
  • Morphine
  • Codeine
  • Semisynthetic Opioids
  • Oxycodone
  • Hydrocodone
  • Hydromorphone
  • Synthetic Opioids
  • Fentanyl
  • Alfentanil
• By Application:
  • Analgesia
  • Cough Suppression
  • Diarrhea Suppression
• By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others (Intramuscular, etc.)
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Endo International plc
  • Lupin Limited
  • Cadila Healthcare Limited
  • Purdue Pharma L.P.
  • AbbVie Inc.
  • Fresenius Kabi
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc.
  • Rhodes Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Limited
  • Nesher Pharmaceuticals (USA) LLC
  • Amneal Pharmaceuticals LLC
  • Trevena Inc.
  • Aurobindo Pharma Limited

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Class
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• Reimbursement Scenario
• PEST Analysis
• PORTER'S Analysis

4. Global Opioid Drugs Market-COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Opioid Drugs Market, By Drug Class, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Alkaloids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Morphine
• codeine
• Semisynthetic Opioids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Oxycodone
• Hydrocodone
• Hydromorphone
• Synthetic Opioids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Fentanyl
• Alfentanil

6. Global Opioid Drugs Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Analgesia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Cough Suppression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Diarrhea Suppression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

7. Global Opioid Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends
• Others (Intramuscular, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Segment Trends

8. Global Opioid Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Opioid Drugs Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Johnson & Johnson
  • Endo International plc
  • Lupin Limited
  • Cadila Healthcare Limited
  • Purdue Pharma L.P.
  • AbbVie Inc.
  • Fresenius Kabi
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc.
  • Rhodes Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Limited
  • Nesher Pharmaceuticals (USA) LLC
  • Amneal Pharmaceuticals LLC
  • Trevena Inc.
  • Aurobindo Pharma Limited

11. Section

• References
• Research Methodology
• About us and Sales Contact